Historical bdx News Stories
BDX Spins Off, $4B Cash, $2B Buybacks Announced Up
Becton, Dickinson completed its Waters merger spin‑off, received $4B in cash, and outlined $2B in accelerated buybacks plus $2B to repay debt. Q1 FY2026 results beat consensus but Life Sciences lagged, driving short-term stock volatility amid mixed analyst reactions.
BDX Tightens Focus After Waters Spin-Off
Becton, Dickinson (BDX) completed the Waters spin-off, received $4 billion in cash, and launched debt buybacks while reporting strong Q4 results alongside reduced FY26 EPS guidance—moves that reshape its capital structure and strategic profile as a pure-play medical technology company.
BDX Waters Deal Closes: $4B Cash, Buybacks & Spin.
Becton, Dickinson & Co. (BDX) completed the Waters reverse Morris Trust spin today, unlocking about $4 billion in proceeds. Management earmarks at least half for share repurchases and the remainder for debt reduction, while new product clearances and AI-driven lab tools support the company’s growth path as it refocuses after the Biosciences/Diagnostics separation.